PT - JOURNAL ARTICLE AU - Zhao, Jiao AU - Yang, Yan AU - Huang, Han-Ping AU - Li, Dong AU - Gu, Dong-Feng AU - Lu, Xiang-Feng AU - Zhang, Zheng AU - Liu, Lei AU - Liu, Ting AU - Liu, Yu-Kun AU - He, Yun-Jiao AU - Sun, Bin AU - Wei, Mei-Lan AU - Li, Yi-Rong AU - Yang, Guang-Yu AU - Wang, Xing-Huan AU - Zhang, Li AU - Zhou, Xiao-Yang AU - Xing, Mingzhao AU - Wang, Peng George TI - Relationship between the ABO Blood Group and the COVID-19 Susceptibility AID - 10.1101/2020.03.11.20031096 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.11.20031096 4099 - http://medrxiv.org/content/early/2020/03/16/2020.03.11.20031096.short 4100 - http://medrxiv.org/content/early/2020/03/16/2020.03.11.20031096.full AB - OBJECTIVE To investigate the relationship between the ABO blood group and the COVID-19 susceptibility.DESIGN The study was conducted by comparing the blood group distribution in 2,173 patients with COVID-19 confirmed by SARS-CoV-2 test from three hospitals in Wuhan and Shenzhen, China with that in normal people from the corresponding regions. Data were analyzed using one-way ANOVA and 2-tailed χ2 and a meta-analysis was performed by random effects models.SETTING Three tertiary hospitals in Wuhan and Shenzhen, China.PARTICIPANTS A total of 1,775 patients with COVID-19, including 206 dead cases, from Wuhan Jinyintan Hospital, Wuhan, China were recruited. Another 113 and 285 patients with COVID-19 were respectively recruited from Renmin Hospital of Wuhan University, Wuhan and Shenzhen Third People’s Hospital, Shenzhen, China.MAIN OUTCOME MEASURES Detection of ABO blood groups, infection occurrence of SARS-CoV-2, and patient death.RESULTS The ABO group in 3694 normal people in Wuhan showed a distribution of 32.16%, 24.90%, 9.10% and 33.84% for A, B, AB and O, respectively, versus the distribution of 37.75%, 26.42%, 10.03% and 25.80% for A, B, AB and O, respectively, in 1,775 COVID-19 patients from Wuhan Jinyintan Hospital. The proportion of blood group A and O in COVID-19 patients were significantly higher and lower, respectively, than that in normal people (both P < 0.001). Similar ABO distribution pattern was observed in 398 patients from another two hospitals in Wuhan and Shenzhen. Meta-analyses on the pooled data showed that blood group A had a significantly higher risk for COVID-19 (odds ratio-OR, 1.20; 95% confidence interval-CI 1.02∼1.43, P = 0.02) compared with non-A blood groups, whereas blood group O had a significantly lower risk for the infectious disease (OR, 0.67; 95% CI 0.60∼0.75, P < 0.001) compared with non-O blood groups. In addition, the influence of age and gender on the ABO blood group distribution in patients with COVID-19 from two Wuhan hospitals (1,888 patients) were analyzed and found that age and gender do not have much effect on the distribution.CONCLUSION People with blood group A have a significantly higher risk for acquiring COVID-19 compared with non-A blood groups, whereas blood group O has a significantly lower risk for the infection compared with non-O blood groups.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNot ApplicableAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are included within the article.